Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cortexyme, Inc. | Interim CEO, COO & CFO | Common Stock | 265K | $249K | $0.94 | Mar 3, 2022 | Direct |
Vincerx Pharma, Inc. | Director | Common Stock | 40K | $38K | $0.95 | Aug 25, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VINC | Vincerx Pharma, Inc. | Aug 24, 2022 | 2 | $49.4K | 4 | Aug 26, 2022 | Director |
VINC | Vincerx Pharma, Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
QNCX | Cortexyme, Inc. | Mar 3, 2022 | 1 | $0 | 4 | Mar 4, 2022 | Interim CEO, COO & CFO |
QNCX | Cortexyme, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | COO & Chief Financial Officer |
QNCX | Cortexyme, Inc. | Nov 16, 2021 | 2 | $66.9K | 4 | Nov 16, 2021 | COO & Chief Financial Officer |
QNCX | Cortexyme, Inc. | Oct 5, 2021 | 3 | -$217K | 4 | Oct 7, 2021 | COO & Chief Financial Officer |
QNCX | Cortexyme, Inc. | Aug 16, 2021 | 9 | -$1.98M | 4 | Aug 18, 2021 | COO & Chief Financial Officer |
VINC | Vincerx Pharma, Inc. | Jun 29, 2021 | 2 | $126K | 4 | Jun 30, 2021 | Director |
QNCX | Cortexyme, Inc. | Jun 28, 2021 | 8 | -$972K | 4 | Jun 30, 2021 | COO & Chief Financial Officer |
VINC | Vincerx Pharma, Inc. | May 13, 2021 | 1 | $0 | 4 | May 14, 2021 | Director |